5.41 USD
▲+0.03+3.05%
盘后 5.13 -2.29%
2026-08-03
市值
$92.94M
市盈率
—
EPS
-1.31
股息率
—
52 周区间
3.28 – 9.82
成交量
28.45K
Beta
1.48
目标价
15.54
52W 低 3.2852W 高 9.82
价格走势
公司简介
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts. It also develops VP-315, an oncolytic peptide-based injectable therapy that is in phase II clinical trial for the treatment of...